A gene medicine with the midkine-mediated transcriptional regulation as new cancer therapeutics

Midkine: From Embryogenesis to Pathogenesis and Therapy

Volumn , Issue , 2012, Pages 237-246

  Tagawa, Masatoshi ^a,b   Kawamura, Kiyoko ^a   Yu, Ling ^a   Tada, Yuji ^b   Hiroshima, Kenzo ^c   Shimada, Hideaki ^d  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Tokyo Women s Medical University   (Japan)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenovirus; Gene therapy; Suicide gene; Transcriptional activation

Indexed keywords

EID: 84893079880     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-4234-5_21     Document Type: Chapter

References (33)

1. Vogelzang NJ, Rusthoven JJ, Symanowski J et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636-2644
2. Ma G, Shimada H, Hiroshima K et al (2008) Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China. Drug Des Devel Ther 2:115-122
3. Ishikawa E, Ooboshi H, Kumai Y et al (2009) Midkine gene transfer protects against focal brain ischemia and augments neurogenesis. J Neurol Sci 285:78-84
4. Sumida A, Horiba M, Ishiguro H et al (2010) Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction. Cardiovasc Res 86:113-121
5. Takei Y, Kadomatsu K, Goto T et al (2006) Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts. Cancer 107:864-873
6. Banno H, Takei Y, Muramatsu T et al (2006) Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg 44:633-641
7. Maehara H, Kaname T, Yanagi K et al (2007) Midkine as a novel target for antibody therapy in osteosarcoma. Biochem Biophys Res Commun 358:757-762
8. Aridome K, Tsutsui J, Takao S et al (1995) Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res 86:655-661
9. Garver RI Jr, Chan CS, Milner PG (1993) Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am J Respir Cell Mol Biol 9:463-466
10. Miyauchi M, Shimada H, Kadomatsu K et al (1999) Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy. Jpn J Cancer Res 90:469-475
11. Miyauchi M, Yoshida Y, Tada Y et al (2001) Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells. Int J Cancer 91:723-727
12. Yoshida Y, Tomizawa M, Bahar R et al (2002) A promoter region of midkine gene can activate transcription of an exogenous suicide gene in human pancreatic cancer. Anticancer Res 22:117-120
13. Tomizawa M, Yu L, Wada A et al (2003) A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter. Br J Cancer 89:1086-1090
14. Yu L, Hamada K, Namba M et al (2004) Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalised and tumour cells. Eur J Cancer 40:1787-1794
15. Yu L, Ugai S, O-Wang J et al (2003) Cell growth- and P53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells. Oncol Rep 10:1301-1305
16. Moolten FL, Wells JM (1990) Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82:297-300
17. Tamaoki T (2000) Human alpha-fetoprotein transcriptional regulatory sequences. Application to gene therapy. Adv Exp Med Biol 465:47-56
18. Wang SC, Hung MC (2001) HER2 overexpression and cancer targeting. Semin Oncol 28:115-124
19. Yu L, Yamamoto N, Kadomatsu K et al (2004) Midkine promoter can mediate transcriptional activation of a fused suicide gene in a broader range of human breast cancer compared with c-erbB-2 promoter. Oncology 66:143-149
20. Jounaidi Y, Doloff JC, Waxman DJ (2007) Conditionally replicating adenoviruses for cancer treatment. Curr Cancer Drug Targets 7:285-301
21. Cody JJ, Douglas JT (2009) Armed replicating adenoviruses for cancer virotherapy. Cancer Gene Ther 16:473-488
22. Adachi Y, Reynolds PN, Yamamoto M et al (2000) Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors. Cancer Res 60:4305-4310
23. Wesseling JG, Yamamoto M, Adachi Y et al (2001) Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma. Cancer Gene Ther 8:990-996
24. Terao S, Shirakawa T, Kubo S et al (2007) Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing human bladder cancer model. Urology 70:1009-1013
25. Kubo S, Kawasaki Y, Yamaoka N et al (2010) Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirus. J Gene Med 12:681-692
26. Maldonado AR, Klanke C, Jegga AG et al (2010) Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors. J Gene Med 12:613-623
27. Kumar S, Gao L, Yeagy B et al (2008) Virus combinations and chemotherapy for the treatment of human cancers. Curr Opin Mol Ther 10:371-379
28. Jiang H, White EJ, Ríos-Vicil CI et al (2011) Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J Virol 85:4720-4729
29. Adachi Y, Reynolds PN, Yamamoto M et al (2001) A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging. Cancer Res 61:7882-7888
30. Maida Y, Kyo S, Sakaguchi J et al (2009) Diagnostic potential and limitation of imaging cancer cells in cytological samples using telomerase-speci fic replicative adenovirus. Int J Oncol 34:1549-1556
31. Kojima T, Hashimoto Y, Watanabe Y et al (2009) A simple biological imaging system for detecting viable human circulating tumor cells. J Clin Invest 119:3172-3181
32. Short JJ, Curiel DT (2009) Oncolytic adenoviruses targeted to cancer stem cells. Mol Cancer Ther 8:2096-2102
33. Maitani Y, Yano S, Hattori Y et al (2006) Liposome vector containing biosurfactant-complexed DNA as herpes simplex virus thymidine kinase gene delivery system. J Liposome Res 16: 359-372